Fundraising Fox

North South VenturesFull Portfolio

13 tracked investments · listed companies and verified rows first

Andromeda Surgicalandromedasurgical.comin𝕏

Andromeda Surgical develops an AI-guided surgical platform that provides GPS-like navigation and autonomous task capabilities to surgeons, starting with endourology procedures.

AI & Machine LearningHealthtechMedical DevicesRoboticsSan Francisco, US

Nick Damiano(Founder)inKartik Tiwari(Founder)in

Co-investorsEarl Grey CapitalNZVCPhaze VenturesRebel FundY CombinatorZelda Ventures+5 more

Commons Cliniccommonsclinic.com

Commons Clinic is an orthopedic care provider offering treatment for spine, joint, and sports medicine conditions, along with preventive health services such as full-body MRI and biomarker labs.

Digital HealthHealthtechWellness & FitnessAustin, US

Brad Hively(Director)Nick Aubin(Founder)inPaulo Marques Da Costa(Executive Officer, Director)Prithviraj Singha Roy(Director)

BoardJohn Loser(Director)inDavid Berry(Director)

Co-investorsCourtside VenturesFloating PointSteelSky VenturesTime BioVenturesAverin CapitalRA Capital

Feanix Biotechnologiesfeanixbio.comin

Feanix Autopilot is an AI-powered platform that combines whole-genome sequencing, farm performance data, and economics to provide herd-level breeding and culling recommendations for dairy farmers.

Advanced ManufacturingAgTechAI & Machine LearningAsheville, US

Mitchell Angove(Founder)inTom Bishop(Founder)in

Co-investorsOverwater Ventures LlcY Combinator

Hormone-Free IVFvitra.bioin

Vitra Bio is a biotechnology company developing technology aimed at transforming fertility treatment.

BiotechFemTechHealthtech

Ivana Muncie-Vasic(Chief Executive Officer and Founder)inJohn Langowski(Chief Technology Officer)in

Co-investorsBreakout VenturesForeground CapitalSpacecadet VenturesBoom Capital VenturesRefactor Capital

Lucislucis.lifein𝕏

Lucis provides personalized health monitoring and guidance by combining laboratory biomarker testing with educational insights and actionable recommendations.

AI & Machine LearningDigital HealthHealthtechWellness & FitnessParis, FR

Max Berthelot(Founder)inBaptiste Debever(Co-founder / CTO)inJulien Do Vale(M.D., MSc, Chief Medical Officer)in

BoardAntoine Andremont(M.D., PHD, President of the scientific board)Jérémy Bos(MD, MSc, Specialist in public health and clinical epidemiology)

Co-investorsCircle & Co.CloverY CombinatorGeneral CatalystSingular

Noetiknoetik.aiin𝕏Sep 2023 · $14M

Noetik builds AI models to identify cancer patients most likely to respond to treatments and to discover new oncology drug targets.

AI & Machine LearningBiotechHealthtechSouth San Francisco, US

Jacob Rinaldi(Executive Officer, Director, Promoter)inRonald Alfa(Executive Officer, Director, Promoter)Ron Alfa, MD, PhD(Founder)in

BoardJames Hardiman(Director)inAmy Schulman(Director)in

Co-investors11.2 CapitalBreakout VenturesLinearis VenturesCatalio Capital ManagementDCVC (Data Collective)EPIC VENTURES+2 more

ParcelBioparcelbio.cominFeb 2026

ParcelBio develops APEXm, a proprietary mRNA platform that enhances protein expression for longer-lasting therapeutic effect compared to conventional mRNA technologies.

AI & Machine LearningBiotechDeep TechHealthtechSan Francisco, US

David Weinberg(Founder)inChris Carlson(Founder)in

BoardMorgan Cheatham(Director)in

Co-investorsY CombinatorBreyer CapitalGeneral CatalystLexi VenturesMetaplanetRitual Capital+3 more

SFA Therapeuticssfatherapeutics.comin𝕏

SFA Therapeutics develops oral therapeutic candidates based on deuterated short-chain fatty acids to treat autoimmune and oncologic diseases.

BiotechHealthtechPhiladelphia, US

Ira Spector(Founder)inAlla Arzumanyan(Founder)inMark Feitelson(Founder)in

Co-investorsAcequia Capital (AceCap)Farvatn VentureImmeasurableY CombinatorBen Franklin Technology Partners

Thumbnail for SyntheXsynthexlabs.comin𝕏

SyntheX develops the ToRFLEx platform, a first-in-class drug discovery technology that enables screening for compounds that modulate protein-protein interactions and targeted protein degradation for previously inaccessible drug targets identified by geneticists.

AI & Machine LearningBiotechDeep Tech

Maria Soloveychik(PhD)in

Co-investorsOMX VenturesThe Column Group8VC

Tiny Healthtinyhealth.comin

Tiny Health offers at-home gut and vaginal microbiome test kits with age-specific, evidence-based reports that recommend diet, supplement, and lifestyle changes.

Digital HealthHealthtechWellness & Fitness

Cheryl Sew Hoy(Founder)in

Co-investorsB Capital GroupB4 CapitalCartan CapitalModi VenturesNext Coast VenturesOverwater Ventures Llc+7 more

Vinemedvinemed.com

Vine Medical develops soft robotic medical devices designed to enhance clinician safety and outcomes during procedures.

HealthtechMedical DevicesRoboticsSanta Barbara, US

David Haggerty, PhD(Co-Founder & Chief Executive Officer)Elliot W. Hawkes, PhD(Co-Founder & Chief Technology Officer)David Drover, MD, FRCP(C)(Co-Founder & Chief Medical Officer)

YourChoiceyourchoicetx.com

YourChoice Therapeutics is developing YCT-529, a non-hormonal oral contraceptive for men currently in Phase 2 clinical trials.

BiotechFemTechHealthtech

Akash Bakshi, MSc(Co-founder & CEO)Nadja Mannowetz, PhD(Co-founder & CSO)

Co-investorsBlue Bear VenturesCivilization Ventures Management, LlcForeground CapitalFuture VenturesPortfoliaOlive Tree Capital+1 more

YourChoice Therapeuticsychoicetx.cominJul 2022

YourChoice Therapeutics develops YCT-529, a non-hormonal oral contraceptive for men currently in Phase 2 clinical trials that works by blocking a receptor essential for sperm production.

BiotechHealthtechMedical DevicesSan Francisco, US

Akash Bakshi(Founder)inNadja Mannowetz(Founder)in

Co-investorsBlue Bear VenturesForeground CapitalOlive Tree CapitalPortfoliaY CombinatorFuture Ventures+1 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.